Characteristics of cases needing advanced treatment for intractable Posner–Schlossman syndrome

Abstract Background In Posner-Schlossman syndrome (PSS), which is characterized by recurrent unilateral attacks of ocular hypertension. Surgical treatment is sometimes necessary because intraocular pressure (IOP) cannot be controlled with anti-glaucoma medications. To identify the clinical features...

Full description

Bibliographic Details
Main Authors: Kazuichi Maruyama, Yuko Maruyama, Sunao Sugita, Kazuhiko Mori, Yu Yokoyama, Shiho Sanuki-Kunimatsu, Hiroko Nakagawa, Shigeru Kinoshita, Manabu Mochizuki, Toru Nakazawa
Format: Article
Language:English
Published: BMC 2017-04-01
Series:BMC Ophthalmology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12886-017-0438-y
_version_ 1819236274595168256
author Kazuichi Maruyama
Yuko Maruyama
Sunao Sugita
Kazuhiko Mori
Yu Yokoyama
Shiho Sanuki-Kunimatsu
Hiroko Nakagawa
Shigeru Kinoshita
Manabu Mochizuki
Toru Nakazawa
author_facet Kazuichi Maruyama
Yuko Maruyama
Sunao Sugita
Kazuhiko Mori
Yu Yokoyama
Shiho Sanuki-Kunimatsu
Hiroko Nakagawa
Shigeru Kinoshita
Manabu Mochizuki
Toru Nakazawa
author_sort Kazuichi Maruyama
collection DOAJ
description Abstract Background In Posner-Schlossman syndrome (PSS), which is characterized by recurrent unilateral attacks of ocular hypertension. Surgical treatment is sometimes necessary because intraocular pressure (IOP) cannot be controlled with anti-glaucoma medications. To identify the clinical features of Posner–Schlossman syndrome (PSS) indicative of the need for intraocular pressure (IOP)-controlling surgery. Methods This study was a retrospective case-series analysis of the clinical charts of 33 patients diagnosed with PSS, who underwent surgery to control IOP or received medication only. Various clinical factors were compared between the surgical and medication groups. Results The surgical group had a higher corneal endothelial cell (CEC) density loss (p < 0.05), higher maximum IOP (p < 0.01), greater visual field loss (p < 0.01) and higher positive number for cytomegalovirus (CMV) (p < 0.001) than the non-surgical group. Eighteen of the 33 patients had a high CEC reduction ratio. Of these 18, 16 required glaucoma surgery. Conclusions PSS patients with a higher CEC reduction ratio, higher maximum IOP, greater visual field loss and higher positive number for CMV in the aqueous humor tended to be more likely to require progressive treatment, such as glaucoma surgery.
first_indexed 2024-12-23T13:01:50Z
format Article
id doaj.art-387d7ac2984b401baf320b8d3b44ce05
institution Directory Open Access Journal
issn 1471-2415
language English
last_indexed 2024-12-23T13:01:50Z
publishDate 2017-04-01
publisher BMC
record_format Article
series BMC Ophthalmology
spelling doaj.art-387d7ac2984b401baf320b8d3b44ce052022-12-21T17:46:00ZengBMCBMC Ophthalmology1471-24152017-04-011711710.1186/s12886-017-0438-yCharacteristics of cases needing advanced treatment for intractable Posner–Schlossman syndromeKazuichi Maruyama0Yuko Maruyama1Sunao Sugita2Kazuhiko Mori3Yu Yokoyama4Shiho Sanuki-Kunimatsu5Hiroko Nakagawa6Shigeru Kinoshita7Manabu Mochizuki8Toru Nakazawa9Department of Ophthalmology and Visual Science, Tohoku University Graduate School of MedicineDepartment of Ophthalmology, Kyoto Prefectural University of MedicineRIKEN Center for Development BiologyDepartment of Ophthalmology, Kyoto Prefectural University of MedicineDepartment of Ophthalmology and Visual Science, Tohoku University Graduate School of MedicineDepartment of Ophthalmology and Visual Science, Tohoku University Graduate School of MedicineDepartment of Ophthalmology, Kyoto Prefectural University of MedicineDepartment of Ophthalmology, Kyoto Prefectural University of MedicineDepartment of Ophthalmology, Tokyo Medical and Dental University, School of MedicineDepartment of Ophthalmology and Visual Science, Tohoku University Graduate School of MedicineAbstract Background In Posner-Schlossman syndrome (PSS), which is characterized by recurrent unilateral attacks of ocular hypertension. Surgical treatment is sometimes necessary because intraocular pressure (IOP) cannot be controlled with anti-glaucoma medications. To identify the clinical features of Posner–Schlossman syndrome (PSS) indicative of the need for intraocular pressure (IOP)-controlling surgery. Methods This study was a retrospective case-series analysis of the clinical charts of 33 patients diagnosed with PSS, who underwent surgery to control IOP or received medication only. Various clinical factors were compared between the surgical and medication groups. Results The surgical group had a higher corneal endothelial cell (CEC) density loss (p < 0.05), higher maximum IOP (p < 0.01), greater visual field loss (p < 0.01) and higher positive number for cytomegalovirus (CMV) (p < 0.001) than the non-surgical group. Eighteen of the 33 patients had a high CEC reduction ratio. Of these 18, 16 required glaucoma surgery. Conclusions PSS patients with a higher CEC reduction ratio, higher maximum IOP, greater visual field loss and higher positive number for CMV in the aqueous humor tended to be more likely to require progressive treatment, such as glaucoma surgery.http://link.springer.com/article/10.1186/s12886-017-0438-yPosner–Schlossman syndrome (PSS)Corneal endothelial cell (CEC) densityIntraocular pressure (IOP)Glaucoma surgeryPolymerase chain reaction (PCR)
spellingShingle Kazuichi Maruyama
Yuko Maruyama
Sunao Sugita
Kazuhiko Mori
Yu Yokoyama
Shiho Sanuki-Kunimatsu
Hiroko Nakagawa
Shigeru Kinoshita
Manabu Mochizuki
Toru Nakazawa
Characteristics of cases needing advanced treatment for intractable Posner–Schlossman syndrome
BMC Ophthalmology
Posner–Schlossman syndrome (PSS)
Corneal endothelial cell (CEC) density
Intraocular pressure (IOP)
Glaucoma surgery
Polymerase chain reaction (PCR)
title Characteristics of cases needing advanced treatment for intractable Posner–Schlossman syndrome
title_full Characteristics of cases needing advanced treatment for intractable Posner–Schlossman syndrome
title_fullStr Characteristics of cases needing advanced treatment for intractable Posner–Schlossman syndrome
title_full_unstemmed Characteristics of cases needing advanced treatment for intractable Posner–Schlossman syndrome
title_short Characteristics of cases needing advanced treatment for intractable Posner–Schlossman syndrome
title_sort characteristics of cases needing advanced treatment for intractable posner schlossman syndrome
topic Posner–Schlossman syndrome (PSS)
Corneal endothelial cell (CEC) density
Intraocular pressure (IOP)
Glaucoma surgery
Polymerase chain reaction (PCR)
url http://link.springer.com/article/10.1186/s12886-017-0438-y
work_keys_str_mv AT kazuichimaruyama characteristicsofcasesneedingadvancedtreatmentforintractableposnerschlossmansyndrome
AT yukomaruyama characteristicsofcasesneedingadvancedtreatmentforintractableposnerschlossmansyndrome
AT sunaosugita characteristicsofcasesneedingadvancedtreatmentforintractableposnerschlossmansyndrome
AT kazuhikomori characteristicsofcasesneedingadvancedtreatmentforintractableposnerschlossmansyndrome
AT yuyokoyama characteristicsofcasesneedingadvancedtreatmentforintractableposnerschlossmansyndrome
AT shihosanukikunimatsu characteristicsofcasesneedingadvancedtreatmentforintractableposnerschlossmansyndrome
AT hirokonakagawa characteristicsofcasesneedingadvancedtreatmentforintractableposnerschlossmansyndrome
AT shigerukinoshita characteristicsofcasesneedingadvancedtreatmentforintractableposnerschlossmansyndrome
AT manabumochizuki characteristicsofcasesneedingadvancedtreatmentforintractableposnerschlossmansyndrome
AT torunakazawa characteristicsofcasesneedingadvancedtreatmentforintractableposnerschlossmansyndrome